Hospital Universitario Fundación Jimenez Díaz

Madrid 28040

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, Carcinoma, Non-Small-Cell Lung, FGFR2 Fusions, Gene Rearrangement, Type 2 Diabetes Mellitus

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes — Running, not enrolling
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed